Drug
Formoterol Fumerate
Formoterol Fumerate: highest development phase Post-Market, developed by Novartis. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Novartis
Trials
| Drug | Phase | Indication |
|---|---|---|
| Formoterol fumerate NCT00460577 | Post-Market | Acute Bronchial Obstruction, Asthma |
Latest
No recent events.
Follow Formoterol Fumerate on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.